Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level-Reference-Cited by-同舟云学术

Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level

Published:2019-12-05 Issue:5 Volume:49 Page:405-411
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Aggarwal R¹,Moghadam-Kia S¹,Lacomis D¹,Malik A¹,Qi Z¹,Koontz D¹,Burlingame RW²,Oddis CV¹

Affiliation:

1. Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA

2. INOVA Diagnostics Inc., San Diego, CA, USA

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03009742.2019.1672782

Reference23 articles.

1. Novel Classification of Idiopathic Inflammatory Myopathies Based on Overlap Syndrome Features and Autoantibodies

2. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes

3. 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands

4. Myopathy with antibodies to the signal recognition particle: clinical and pathological features

5. Review: Immune-mediated necrotizing myopathies - a heterogeneous group of diseases with specific myopathological features

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of an immunoprecipitation assay for detecting anti‐3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase autoantibodies using a non‐radioactive biotinylated recombinant protein;Clinical and Experimental Neuroimmunology;2024-08-18

2. Distinct phenotype and prognosis of immune-mediated necrotizing myopathy based on clinical–serological–pathological classification;Rheumatology;2024-07-19

3. Breaking down statin myopathy: understanding the self-limited and autoimmune subtypes;Rheumatology;2024-06-03

4. Management of immune‐mediated necrotizing myopathy;Muscle & Nerve;2024-05-27

5. Clinical and persistent remission in anti-HMGCR immune-mediated necrotizing myopathy to a single cycle of rituximab – a case-based review;ARP Rheumatology;2024-05-18